ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
31 hedge funds and large institutions have $5.42M invested in Acorda Therapeutics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Holders
31
Holding in Top 10
–
Calls
$63K
Puts
$6K
Top Buyers
| 1 | +$22K | |
| 2 | +$3.97K | |
| 3 | +$3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$808 |
Top Sellers
| 1 | -$674K | |
| 2 | -$186K | |
| 3 | -$129K | |
| 4 |
Millennium Management
New York
|
-$80.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$73K |